Translational Development Acquisition Corp. (NASDAQ:TDACU) Short Interest Up 200.0% in July

Translational Development Acquisition Corp. (NASDAQ:TDACU) was the recipient of a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 3 shares, a growth of 200.0% from the July 15th total of 1 shares. Based on an average daily trading volume, of 87 shares, the short-interest ratio is currently 0.0 days.

Translational Development Acquisition Stock Performance

Translational Development Acquisition stock traded down $0.66 during mid-day trading on Thursday, hitting $11.91. Translational Development Acquisition has a 52 week low of $10.71 and a 52 week high of $17.29. The business has a fifty day moving average of $12.03 and a 200-day moving average of $11.18.

Translational Development Acquisition Company Profile

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.